Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.

Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, Burton DR.

Cell Rep. 2018 Jan 23;22(4):1103. doi: 10.1016/j.celrep.2017.10.089. Epub 2018 Jan 28. No abstract available.

2.

Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.

Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR.

Immunity. 2017 Nov 21;47(5):1004. doi: 10.1016/j.immuni.2017.10.012. No abstract available.

3.

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.

Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, Burton DR.

Cell Rep. 2017 Oct 3;21(1):222-235. doi: 10.1016/j.celrep.2017.09.024. Erratum in: Cell Rep. 2018 Jan 23;22(4):1103.

4.

Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.

Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR.

Immunity. 2017 Sep 19;47(3):524-537.e3. doi: 10.1016/j.immuni.2017.08.006. Epub 2017 Sep 12. Erratum in: Immunity. 2017 Nov 21;47(5):1004.

5.

Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.

Voss JE, Macauley MS, Rogers KA, Villinger F, Duan L, Shang L, Fink EA, Andrabi R, Colantonio AD, Robinson JE, Johnson RP, Burton DR, Haase AT.

AIDS. 2016 Oct 23;30(16):2427-2438.

6.

Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies.

McCoy LE, van Gils MJ, Ozorowski G, Messmer T, Briney B, Voss JE, Kulp DW, Macauley MS, Sok D, Pauthner M, Menis S, Cottrell CA, Torres JL, Hsueh J, Schief WR, Wilson IA, Ward AB, Sanders RW, Burton DR.

Cell Rep. 2016 Aug 30;16(9):2327-38. doi: 10.1016/j.celrep.2016.07.074. Epub 2016 Aug 18.

7.

Mucosal Humoral Immune Response to SIVmac239∆nef Vaccination and Vaginal Challenge.

Zeng M, Smith AJ, Shang L, Wietgrefe SW, Voss JE, Carlis JV, Li Q, Piatak M Jr, Lifson JD, Johnson RP, Haase AT.

J Immunol. 2016 Mar 15;196(6):2809-18. doi: 10.4049/jimmunol.1500156. Epub 2016 Feb 10.

8.

Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.

Andrabi R, Voss JE, Liang CH, Briney B, McCoy LE, Wu CY, Wong CH, Poignard P, Burton DR.

Immunity. 2015 Nov 17;43(5):959-73. doi: 10.1016/j.immuni.2015.10.014.

9.

Co-evolution of quaternary organization and novel RNA tertiary interactions revealed in the crystal structure of a bacterial protein-RNA toxin-antitoxin system.

Rao F, Short FL, Voss JE, Blower TR, Orme AL, Whittaker TE, Luisi BF, Salmond GP.

Nucleic Acids Res. 2015 Oct 30;43(19):9529-40. doi: 10.1093/nar/gkv868. Epub 2015 Sep 8.

10.

What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?

Alexander MR, Ringe R, Sanders RW, Voss JE, Moore JP, Klasse PJ.

J Virol. 2015 Jun;89(11):5981-95. doi: 10.1128/JVI.00320-15. Epub 2015 Mar 25.

11.

Molecular recognition of RhlB and RNase D in the Caulobacter crescentus RNA degradosome.

Voss JE, Luisi BF, Hardwick SW.

Nucleic Acids Res. 2014 Dec 1;42(21):13294-305. doi: 10.1093/nar/gku1134. Epub 2014 Nov 11.

12.

Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.

Li Q, Zeng M, Duan L, Voss JE, Smith AJ, Pambuccian S, Shang L, Wietgrefe S, Southern PJ, Reilly CS, Skinner PJ, Zupancic ML, Carlis JV, Piatak M Jr, Waterman D, Reeves RK, Masek-Hammerman K, Derdeyn CA, Alpert MD, Evans DT, Kohler H, Müller S, Robinson J, Lifson JD, Burton DR, Johnson RP, Haase AT.

J Immunol. 2014 Sep 15;193(6):3113-25. doi: 10.4049/jimmunol.1400820. Epub 2014 Aug 18.

13.

Structure of the AcrAB-TolC multidrug efflux pump.

Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, Chiu W, Luisi BF.

Nature. 2014 May 22;509(7501):512-5. doi: 10.1038/nature13205. Epub 2014 Apr 20.

14.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3.

15.

Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein.

Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Mégret F, Guittet E, Rey FA, Flamand M.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):8003-8. doi: 10.1073/pnas.1017338108. Epub 2011 Apr 25.

16.

Correct assembly of iron-sulfur cluster FS0 into Escherichia coli dimethyl sulfoxide reductase (DmsABC) is a prerequisite for molybdenum cofactor insertion.

Tang H, Rothery RA, Voss JE, Weiner JH.

J Biol Chem. 2011 Apr 29;286(17):15147-54. doi: 10.1074/jbc.M110.213306. Epub 2011 Feb 26.

17.

Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography.

Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA.

Nature. 2010 Dec 2;468(7324):709-12. doi: 10.1038/nature09555.

PMID:
21124458
18.

Substrate-mediated stabilization of a tetrameric drug target reveals Achilles heel in anthrax.

Voss JE, Scally SW, Taylor NL, Atkinson SC, Griffin MD, Hutton CA, Parker MW, Alderton MR, Gerrard JA, Dobson RC, Dogovski C, Perugini MA.

J Biol Chem. 2010 Feb 19;285(8):5188-95. doi: 10.1074/jbc.M109.038166. Epub 2009 Nov 30.

19.

Expression, purification, crystallization and preliminary X-ray diffraction analysis of dihydrodipicolinate synthase from Bacillus anthracis in the presence of pyruvate.

Voss JE, Scally SW, Taylor NL, Dogovski C, Alderton MR, Hutton CA, Gerrard JA, Parker MW, Dobson RC, Perugini MA.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Feb 1;65(Pt 2):188-91. doi: 10.1107/S1744309109000670. Epub 2009 Jan 31.

20.

Pins and their relation to cavity resistance form for amalgam.

Buikema DJ, Mayhew RB, Voss JE, Bales DJ.

Quintessence Int. 1985 Mar;16(3):187-90. No abstract available.

PMID:
3857664
21.

Gingival response to laminate veneer restorations.

Barham TP Jr, Mayhew RB, Cowan RD, Lubow RM, Pierson WP, Voss JE.

Oper Dent. 1983 Autumn;8(4):122-9. No abstract available.

PMID:
6366763
22.

A six-month clinical evaluation of polishing techniques on the marginal integrity of a high-copper alloy.

Schmelitzer LD, Mayhew RB, Cowan RD, Voss JE.

J Indiana Dent Assoc. 1982 Sep-Oct;61(5):17-9. No abstract available.

PMID:
6962253
23.

A clinical evaluation of a high-copper alloy containing palladium.

Hermesch CB, Voss JE, Bales DJ, Mayhew RB.

J Indiana Dent Assoc. 1982 Sep-Oct;61(5):13-5. No abstract available.

PMID:
6962252
24.

A clinical comparison of three tooth-colored restorative resins.

Davis RD, Mayhew RB, Voss JE.

J Indiana Dent Assoc. 1982 Sep-Oct;61(5):9-12. No abstract available.

PMID:
6219164
25.
26.

Normal but Undomesticated.

Voss JE.

Psychol Clin. 1930 May;19(3):96-99. No abstract available.

Supplemental Content

Support Center